In conclusion, our findings suggest that astrocyte ephrinB2 upregulation is both a signaling mechanism underlying astrocyte pathogenicity in mutant SOD1-associated ALS and a promising therapeutic target. This evidence concerns the gene EFNB2 and amyotrophic lateral sclerosis.